For a 46‑year‑old man with type 3c diabetes, weight 88 kg, creatinine 1.18 mg/dL (eGFR ≈ 77 mL/min) on Lantus (insulin glargine) 10 U daily, insulin‑to‑carbohydrate ratio 10 g per unit, insulin sensitivity factor 50 mg/dL per unit, with capillary glucose 263 mg/dL at 1700 h, 231 mg/dL at 0200 h, and 284 mg/dL at 0700 h after meals of 80 g, 82 g, and 34 g carbohydrates, what should the basal insulin dose, insulin sensitivity factor, and insulin‑to‑carbohydrate ratio be adjusted to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Insulin Dose Adjustment Recommendations

Increase your Lantus to 20 units daily (doubling from 10 to 20 units), tighten your insulin-to-carbohydrate ratio from 1:10 to 1:8, and adjust your insulin sensitivity factor from 50 to 40 mg/dL per unit.

Rationale for Basal Insulin Adjustment

Your overnight glucose pattern reveals inadequate basal coverage. Despite no carbohydrate intake between 2100h and 0700h, your glucose rose from 231 to 284 mg/dL—a 53 mg/dL increase over 10 hours. This demonstrates clear basal insulin insufficiency 1.

Following the ADA 2025 guidelines, when fasting plasma glucose remains elevated despite current basal insulin, increase the dose by 2 units every 3 days until reaching target 1. However, given your significant hyperglycemia (fasting glucose 284 mg/dL, well above any reasonable target), a more aggressive initial adjustment is warranted.

Your current dose of 10 units represents only 0.11 units/kg (10 units ÷ 88 kg). The standard starting range is 0.1-0.2 units/kg daily 1, and you're at the lower end. Doubling to 20 units (0.23 units/kg) remains well below the 0.5 units/kg threshold where diminishing returns occur 2. Research demonstrates that basal insulin doses above 0.5 units/kg/day show plateauing glycemic benefit with increased weight gain 2, so you have substantial room for safe escalation.

Prandial Insulin Adjustments

Insulin-to-Carbohydrate Ratio (ICR)

Your current 1:10 ratio is insufficient. You consumed 196g total carbohydrates (80 + 82 + 34g) requiring approximately 19.6 units of bolus insulin by your current calculation, yet your glucose remained elevated throughout.

The "500 rule" (500 ÷ total daily dose) is outdated. Research using continuous glucose monitoring shows the more accurate formula is 300-400 ÷ TDD 3, 4. With breakfast requiring more insulin due to dawn phenomenon and insulin resistance, use 300 for breakfast and 400 for lunch/dinner 5, 3.

Your current total daily dose is approximately 30 units (10 basal + ~20 bolus). Using the corrected formulas:

  • Breakfast ICR: 300 ÷ 30 = 1:10 (your current ratio is barely adequate for breakfast only)
  • Lunch/Dinner ICR: 400 ÷ 30 = 1:13 (you're significantly under-dosing at other meals)

After increasing Lantus to 20 units, your new TDD will be approximately 40 units. Recalculate:

  • Breakfast ICR: 300 ÷ 40 = 1:7.5 (round to 1:8)
  • Lunch/Dinner ICR: 400 ÷ 40 = 1:10

Insulin Sensitivity Factor (ISF)

Your ISF of 50 mg/dL per unit is too weak. The "1500 rule" (1500 ÷ TDD) provides better estimates than the outdated "1800 rule" 4.

With current TDD of 30 units: 1500 ÷ 30 = 50 mg/dL per unit (your current setting)

After increasing to TDD of 40 units: 1500 ÷ 40 = 37.5 mg/dL per unit (round to 40)

This tighter correction factor will more effectively address hyperglycemia.

Type 3c Diabetes Considerations

Type 3c diabetes (pancreatogenic) often requires both insulin and pancreatic enzyme replacement. These patients typically need higher insulin doses due to malabsorption and counter-regulatory hormone deficiencies. Your relatively preserved renal function (eGFR 77 mL/min) does not require dose reduction—insulin dose adjustments for renal impairment typically begin at eGFR <45 mL/min 6.

Implementation Algorithm

  1. Tonight: Increase Lantus from 10 to 20 units (taken at your usual time)
  2. Tomorrow: Implement new ratios:
    • Breakfast: 1 unit per 8g carbohydrate
    • Lunch/Dinner: 1 unit per 10g carbohydrate
    • Correction doses: 1 unit per 40 mg/dL above target
  3. Monitor fasting glucose daily for 3 days
  4. If fasting glucose remains >130 mg/dL after 3 days: Increase Lantus by 2 units every 3 days until fasting glucose 80-130 mg/dL 1
  5. If hypoglycemia occurs (<70 mg/dL): Reduce corresponding insulin component by 10-20% 1

Critical Pitfalls to Avoid

  • Do not wait weeks between adjustments when glucose is this elevated—therapeutic inertia worsens outcomes 1
  • Do not use the same ICR for all meals—breakfast requires more insulin than lunch/dinner 5, 3
  • Do not exceed 0.5 units/kg basal insulin (44 units for your weight) without adding GLP-1 RA or intensifying prandial coverage 2
  • Ensure glucagon availability for emergency hypoglycemia treatment 1

Your mild renal impairment (Cr 1.18, eGFR 77) requires monitoring but does not necessitate dose reduction at this stage 6.

References

4
Research

How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2010

Related Questions

If I lower the insulin-to-carbohydrate ratio on my insulin pump and increase the insulin sensitivity factor, will these changes balance each other out?
For a 46‑year‑old man with type 3c diabetes, weight 88 kg, impaired renal function (creatinine 1.18 mg/dL, eGFR ≈ 77 mL/min) who is on Lantus (insulin glargine) 10 U daily, insulin‑to‑carbohydrate ratio 10 g per unit, and insulin‑sensitivity factor 50 mg/dL per unit, is it appropriate to increase basal Lantus to 15 U, adjust the insulin‑sensitivity factor to 25 mg/dL per unit, and set the insulin‑to‑carbohydrate ratio to 1 U per 8 g carbohydrate?
Would a 40% reduction in insulin dose correspond to an insulin-to-carbohydrate ratio of 1 unit per 8 g of carbohydrate?
For a 45-year-old male weighing 98.4 kg with newly diagnosed diabetes (A1C 14.5%) on an insulin drip titrated to 13 units per hour, receiving 1 unit per 10 g carbohydrate for an 80‑g carbohydrate load, what should his insulin‑to‑carbohydrate ratio be?
What is the carbohydrate-to-insulin ratio when 3 units of insulin cover one carb choice, expressed as 1 unit per how many grams of carbohydrate?
In a patient with lower extremity electromyography (EMG) indicating S1 radiculopathy, how likely is the radiculopathy to resolve such that a repeat EMG performed 1–2 years later will be normal?
In a female patient with left lower quadrant pain and burning sensation during bowel movements and dyslipidemia (elevated total cholesterol, elevated triglycerides, and elevated LDL cholesterol), what is the appropriate workup and is an abdominal ultrasound sufficient?
In a patient with decompensated cirrhosis (Child‑Pugh B or C), should the metronidazole dose be reduced from 500 mg intravenous twice daily to 500 mg intravenous once daily?
For a 46‑year‑old man with type 3c diabetes, weight 88 kg, impaired renal function (creatinine 1.18 mg/dL, eGFR ≈ 77 mL/min) who is on Lantus (insulin glargine) 10 U daily, insulin‑to‑carbohydrate ratio 10 g per unit, and insulin‑sensitivity factor 50 mg/dL per unit, is it appropriate to increase basal Lantus to 15 U, adjust the insulin‑sensitivity factor to 25 mg/dL per unit, and set the insulin‑to‑carbohydrate ratio to 1 U per 8 g carbohydrate?
What are the definitions of denervation and reinnervation in a patient with an EMG demonstrating S1 radiculopathy?
Which infections and medications can trigger the development of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in a 35-year-old male?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.